Search

everythinglearnresearchcommunity

for

Search:↓

The document concludes that Telogen Effluvium is a hair loss disorder that can be assessed with the modified wash test and may be treated with clobetasol foam, with patient management being important.

Many women with hair loss also have thyroid issues, high blood pressure, and low Vitamin D.

ALRV5XR significantly improves hair density in women with hair loss and is well-tolerated.

Injecting scalp tissue micrografts is a safe and effective treatment for hair loss after COVID-19.

COVID-19 infection can cause new hair loss conditions or worsen existing skin diseases, with hair loss being the most common issue.

More atypical club hairs may indicate Telogen Effluvium.

Over half of the participants in a Saudi Arabian survey experienced hair loss after COVID-19, affecting women and younger people more, with a small percentage feeling a severe impact on their lives.

Red LED light therapy helps reduce hair loss and improves hair regrowth in long COVID patients.

Hormones like androgens, estrogen, thyroid hormones, and stress hormones can contribute to hair loss, and treatments target these hormonal imbalances.

Oral Vitamin D can improve hair density and reduce hair loss in Telogen Effluvium patients.

Hair loss can happen after both mild and severe COVID-19, and areas with more COVID-19 cases may see more hair loss cases.

Many young men with hair loss have low levels of vitamin D and B12.

Nourkrin® Woman with Marilex® improves hair growth, appearance, and confidence in women with hair loss.

Vitamin D deficiency is common in people with certain types of hair loss, like alopecia areata and female pattern hair loss.

Combining PRP with Tressfix Serum is more effective for hair regrowth in telogen effluvium than using either alone.

SETDB1 is essential for controlling DNA methylation, silencing retrotransposons, and maintaining skin cell health, with its absence leading to skin inflammation and hair loss.

COVID-19 infection can significantly cause temporary hair loss.

Weight loss can cause temporary hair loss, especially in women and older adults.

Alopecia areata is an incurable autoimmune condition causing hair loss, with research aiming for better treatments.

Finasteride may increase the risk of suicide or severe self-harm in men with mood disorders but not in the general population.

New treatments for hair loss should target eight main causes and use specific plant compounds and peptides for better results.

Iontophoresis with growth factors safely and effectively promotes hair regrowth without discomfort.

Iron deficiency anemia may contribute to hair loss in women with Telogen effluvium.

Finasteride may help treat kidney disease caused by a high-fat diet by reducing harmful toxins and improving gut bacteria.

Scalp microneedling may improve hair density and thickness for various alopecia types.

Finasteride reduces gambling symptoms in Parkinson's patients.

Female authorship in dermatology publications increased during the COVID-19 pandemic, but women are still underrepresented in senior roles.

Transgender patients on hormone therapy experience more acne and hair loss, but less skin inflammation.

The treatment improved hair growth and thickness in patients with hair loss, even 10 months after therapy without additional products.

Adult female acne requires a comprehensive treatment approach, including medical options and lifestyle changes, with attention to psychological well-being.